Lung Cancer Screening and Prevention Act of 2025
Sponsor

Full profile: /officials/B001260
Source: Congress.gov · FEC
Cosponsors (9)
Members who have signed on to support this bill since introduction. Source: Congress.gov.
- Darin LaHood (R-IL-16)Original· 2025-02-18
- Darren Soto (D-FL-9)Original· 2025-02-18
- Debbie Wasserman Schultz (D-FL-25)Original· 2025-02-18
- H. Morgan Griffith (R-VA-9)Original· 2025-02-18
- Timothy M. Kennedy (D-NY-26)Original· 2025-02-18
- Robert P. Bresnahan, Jr. (R-PA-8)· 2025-10-03
- Joe Neguse (D-CO-2)· 2025-11-20
- Paul Tonko (D-NY-20)· 2026-01-07
Latest Action
The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2025-02-18
Source: Congress.gov
Committee Activity
Currently in
- House Committee on Ways and MeansReferred To · 2025-02-18
- House Committee on Energy and CommerceReferred To · 2025-02-18
Plain-English Summary
Lung Cancer Screening and Prevention Act of 2025 This bill authorizes Medicare coverage of additional types of lung cancer screening tests that are approved by the Food and Drug Administration, regardless of whether they are recommended by the United States Preventive Services Task Force. The Centers for Medicare & Medicaid Services must set coverage and payment limits for such tests. (Currently, Medicare covers screening tests for the early detection of lung cancer if they are recommended by the task force.)
Plain-English rewrite of the Congressional Research Service summary published on Congress.gov. Cached and reviewed.
Subjects
Full Bill Text
Verbatim text published on Congress.gov via GovInfo. Use Cmd+F / Ctrl+F to search within this excerpt.
[Congressional Bills 119th Congress] [From the U.S. Government Publishing Office] [H.R. 1406 Introduced in House (IH)] <DOC> 119th CONGRESS 1st Session H. R. 1406 To amend title XVIII of the Social Security Act to authorize the coverage of additional lung cancer screening tests under the Medicare program. _______________________________________________________________________ IN THE HOUSE OF REPRESENTATIVES February 18, 2025 Mr. Buchanan (for himself, Mr. Kennedy of New York, Mr. Griffith, Mr. LaHood, Mr. Soto, and Ms. Wasserman Schultz) introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned _______________________________________________________________________ A BILL To amend title XVIII of the Social Security Act to authorize the coverage of additional lung cancer screening tests under the Medicare program. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE. This Act may be cited as the ``Lung Cancer Screening and Prevention Act of 2025''. SEC. 2. AUTHORITY TO EXPAND COVERAGE OF TESTS FOR LUNG CANCER SCREENING UNDER THE MEDICARE PROGRAM. (a) In General.--Section 1834(n) of the Social Security Act (42 U.S.C. 1395m(n)) is amended-- (1) by redesignating subparagraphs (A) and (B) of paragraph (1) as clauses (i) and (ii), respectively, with appropriate indentation; (2) by redesignating paragraphs (1) and (2) as subparagraphs (A) and (B), respectively, with appropriate indentation; (3) by striking ``Notwithstanding any other provision of this title'' and inserting: ``(1) In general.--Notwithstanding any other provision of this title and subject to paragraph (2)''; and (4) by adding at the end the following new paragraph: ``(2) Authority to cover new lung cancer screening tests as preventive services.-- ``(A) In general.--Notwithstanding paragraph (1), in addition to preventive services consisting of screening tests for the early detection of lung cancer covered under this part pursuant to national coverage determination 210.14, the Secretary may provide for coverage under this part of other lung cancer screening tests that are cleared or approved by the Food and Drug Administration as preventive services when furnished to appropriate individuals (as determined by the Secretary), with such frequency and payment limits as the Secretary determines appropriate in consultation with appropriate organizations. ``(B) Use of national coverage determination process.-- ``(i) In general.--Coverage of other lung cancer screening tests under subparagraph (A) shall be determined using the process for making national coverage determinations (as defined in section 1869(f)(1)(B)), except that there shall be no requirement for a determination under section 1861(ddd)(3)(B) with respect to such test under such process. ``(ii) Rule of construction.--Nothing in clause (i) shall be construed as preventing the Secretary from considering recommendations made by entities with expertise in preventive services, including entities convened by the Secretary or the Director of the Agency for Healthcare Research and Quality, with respect to other lung cancer screening tests described in subparagraph (A).''. (b) Effective Date.--The amendments made by subsection (a) shall take effect on the date of the enactment of this Act, and apply with respect to coverage of preventive services under Part B of title XVIII of the Social Security Act (42 U.S.C. 1395j et seq.) on or after such date. <all>
Related legislation
Bills by the same sponsor or covering overlapping subjects.
- HR8959Semiconductor Superiority ActReferred to Committee · 2026-05-21
- HR5347Health Care Efficiency Through Flexibility ActReported by Committee · 2026-05-21
- HR7786AI Fraud Accountability ActReferred to Committee · 2026-03-04
- HR6513MINKS are Superspreaders ActReferred to Committee · 2026-01-13